Associate Clinical Professor, Cardiology, Columbia University College of Physicians and Surgeons
Cardiology
Dr. Mark Heiman, MD
|
|
Give Review
Dr. Mark Heiman works in the field of Cardiology. He researched medicine at Albert Einstein College of Medicine. He over the years received 4 awards: "Top Doctors: New York Metro Area", "Greenwich Magazine", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Doctor Mark Heiman, MD is also a published doctor. He has 83 paper published. The most recent paper is: Changes in leptin expression are not associated with corresponding changes in CCAAT/enhancer binding protein-alpha. He is registered with Medicare and accepts Medicare payments.
Publications
- Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels.
- The obstetric, gynaecological and fertility implications of homozygous PAI-1 deficiency: single-centre experience.
- Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat.
- Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand Disease.
- Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C-->T mutation.
- Administration of human pancreatic growth hormone-releasing factor (GRF) analogs enhances responsiveness of cultured rat pituitary cells to GRF.
- Dopaminergic receptors in the rat anterior pituitary change during the estrous cycle.
- Rat anterior pituitary dopaminergic receptors are regulated by estradiol and during lactation.
- Adenohypophyseal response to hypophysiotropic hormones in male obese Zucker rats.
- Leptin: structure, function and biology.
- Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis.
- Novel polymorphism of the human ob gene promoter in lean and morbidly obese subjects.
- Markers for the gene ob and serum leptin levels in human morbid obesity.
- Prolonged inhibition of growth hormone secretion by peripheral injection of bombesin is mediated by somatostatin in the rat.
- Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels.
- Differential effects of N-terminal modifications on the biological potencies of growth hormone releasing factor analogues with varying chain lengths.
- Solid-phase synthesis and biological properties of psi [CH2NH] pseudopeptide analogues of a highly potent somatostatin octapeptide.
- Strategies in the design of synthetic agonists and antagonists of growth hormone releasing factor.
- Elevated umbilical cord ghrelin concentrations in small for gestational age neonates.
- The effect of exercise on leptin concentration in healthy men and in type 1 diabetic patients.
- Leptin and thermogenesis in humans.
- Restoration of juvenile baseline growth hormone secretion with preservation of the ultradian growth hormone rhythm by continuous delivery of growth hormone-releasing f...
- Ultradian oscillations of leptin secretion in humans.
- Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinoma.
- Serum leptin concentration and fuel homeostasis in healthy man.
- Production and biological activity of hybrid growth hormone-releasing hormone propeptides.
- An extremely sensitive in vitro model for elucidating structure-activity relationships of growth hormone-releasing factor analogs.
- Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1...
- Radioimmunoassay of rat leptin: sexual dimorphism reversed from humans.
- Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa.
- Sexual dimorphic porcine pituitary response to growth hormone-releasing hormone.
- Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting.
- Serum immunoreactive-leptin concentrations in normal-weight and obese humans.
- Differential brain responses to satiation in obese and lean men.
- Chronic leptin administration promotes lipid utilization until fat mass is greatly reduced and preserves lean mass of normal female rats.
- Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity.
- Synthesis of PCR-derived, single-stranded DNA probes suitable for in situ hybridization.
- Characterization of growth hormone-releasing hormone (GHRH) binding to cloned porcine GHRH receptor.
- Changes in leptin expression are not associated with corresponding changes in CCAAT/enhancer binding protein-alpha.
- Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.
- Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects.
- Leptin synthesis is resistant to Acute effects of insulin in insulin-dependent diabetes mellitus patients.
- Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
- Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet.
- Physiology: does gut hormone PYY3-36 decrease food intake in rodents?
- Minireview: ghrelin and the regulation of energy balance--a hypothalamic perspective.
- Rodent obesity models: an overview.
- Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats.
- Circulating ghrelin levels are decreased in human obesity.
- Increased weight gain after ovariectomy is not a consequence of leptin resistance.
- Ghrelin induces adiposity in rodents.
- Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress.
- Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone.
- Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins.
- GOAT links dietary lipids with the endocrine control of energy balance.
- Fat and water 1H MRI to investigate effects of leptin in obese mice.
- Overview of rodent models for obesity research.
- Ghrelin in obesity.
- GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.
- Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents.
- Potent oxindole based human beta3 adrenergic receptor agonists.
- Structure-activity relationships of beta-MSH derived melanocortin-4 receptor peptide agonists.
- Potent benzimidazolone based human beta(3)-adrenergic receptor agonists.
- A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in di...
- Potent and selective MC-4 receptor agonists based on a novel disulfide scaffold.
- Potent peptide agonists for human melanocortin 3 and 4 receptors derived from enzymatic cleavages of human beta-MSH(5-22) by dipeptidyl peptidase I and dipeptidyl pept...
- Discovery of a beta-MSH-derived MC-4R selective agonist.
- Synthesis and biological evaluation of an orally active ghrelin agonist that stimulates food consumption and adiposity in rats.
- Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.
- Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis.
- Galanin-like peptide functions more like leptin than like galanin.
- Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis.
- Peptides that regulate food intake: antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization.
- Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice.
- The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.
- Plasma ghrelin, obesity, and the polycystic ovary Syndrome: correlation with insulin resistance and androgen levels.
- High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi Syndrome.
- Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats.
- Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabo...
- Role of ghrelin polymorphisms in obesity based on three different studies.
- Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique Primary structure.
- Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity.
Schools
Albert Einstein College of Medicine of Yeshiva University
Colum Presby
Montefiore Med Center
Albert Einstein College Med
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Top Doctors: New York Metro Area
- Greenwich Magazine
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Albert Einstein College of Medicine -
Albert Einstein - Montefiore Medical Center -
New York Presbyterian Hospital - Columbia Campus -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
Greenwich Hospital -
Stamford Hospital
Drug Facts
| NPI NUMBER | 1447278064 | |
| NPPES Provider LastName | HEIMAN | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 069055572 | |
| NPPES Provider State | CT | |
| Specialty Description | Cardiology | |
| Total Claim Count | 2119.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447278064 |
| Last Name Of The Provider | HEIMAN |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Joseph J. Tiano, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jared G. Selter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael R. Pittaro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey Berman, MD |
|
Dr. Robert D. Sackstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sik Hur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Jumper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Avinash R. Gulrajani, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David Lorenz, MD |